Inventor · disambiguated record
Ramkumar Rajamani
Also filed as: RAJAMANI RAMKUMAR
19 granted patents·9 pending applications·31 citations·filing 2007–2024
91Inventor score
Files withBRISTOL MYERS SQUIBB CO18HIEBERT SHELDON2LILLY CO ELI2VIIV HEALTHCARE UK NO 5 LTD2XENON PHARMACEUTICALS INC2
Top patents by PatentIndex Score
28 records- 0190US10954252B1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Granted Mar 23, 2021·6 cites·11 claims
- 0286US11505543B24-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Nov 22, 2022·3 cites·4 claims
- 0379US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 0476US10253027B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 9, 2019·3 cites·6 claims
- 0576US9708337B2Aryl amide-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 18, 2017·3 cites·10 claims
- 0675US8957203B2Hepatitis C virus inhibitorsHIEBERT SHELDON·Filed 2012·Granted Feb 17, 2015·4 cites·3 claims
- 0774US8563505B2Hepatitis C virus inhibitorsHIEBERT SHELDON·Filed 2009·Granted Oct 22, 2013·4 cites·10 claims
- 0874US2025214970A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0972US8044087B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 25, 2011·1 cites·17 claims
- 1071US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 1170US8343999B2Thiazolyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 1, 2013·1 cites·4 claims
- 1269US8703953B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 22, 2014·1 cites·8 claims
- 1367US8901305B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 2, 2014·1 cites·11 claims
- 1466US9527885B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 1564US2023203007A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1661US8383821B2NK-1 and serotonin transporter inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 26, 2013·0 cites·9 claims
- 1760US2024368193A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1857US2024343736A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1954US2016199372A1Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophreniaBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2053US8969564B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 3, 2015·0 cites·3 claims
- 2153US2007249607A1Nk-1 and serotonin transporter inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2250US2010080770A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2346US9737542B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·0 cites·7 claims
- 2443US2016222021A1Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2543US2016333006A1Aryl lacta kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2635US10035777B2Heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 31, 2018·0 cites·12 claims
- 2735US8604024B2Compounds for the reduction of beta-amyloid productionTHOMPSON III LORIN A·Filed 2012·Granted Dec 10, 2013·0 cites·8 claims
- 2833US8691757B2Hepatitis C virus inhibitorsRAJAMANI RAMKUMAR·Filed 2012·Granted Apr 8, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →